30 October 2025
Quarters $ million Nine months Q3 2025 Q2 2025 Q3 2024 %¹ Reference 2025 2024 % 5,322 3,601 4,291 +48…
Hansa Investment Company Ltd Half-Year Report 30 October 2025 The power of investing differently We are globally diversified, multi-asset class investors who seek to…
29 October 2025
Primary Health Properties PLC (“PHP”, the “Group” or the “Company”) 2025 Annual General Meeting – Voting Results Update Statement At the Company’s Annual General Meeting…
Hargreaves Services plc (“Hargreaves”, the “Company” or the “Group”) AGM Statement and Notice of Interim Results Hargreaves Services plc (AIM: HSP), a diversified group delivering services…
GSK delivers strong Q3 performance and upgrades 2025 guidance Specialty Medicines, Vaccines and General Medicines drive sales, profit and earnings growth (Financial Performance –…
28 October 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives Orphan Drug Designation in the EU GSK plc (LSE/NYSE: GSK) today announced that GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate…
B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Sale of Stewart Specialty Risk Underwriting Limited B.P. Marsh & Partners Plc…
COLEFAX GROUP PLC (the “Company”) Result of Tender Offer Purchase of Own Shares and Total Voting Rights The Company (AIM:CFX) is pleased to announce…